A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer.
about
Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.An implantable compound-releasing capsule triggered on demand by ultrasound.Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancerCombinations in multimodality treatments and clinical outcomes during cancerA preclinical system prototype for focused microwave thermal therapy of the breast.Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array.Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.Absolute temperature imaging using intermolecular multiple quantum MRIHyperthermia for locally advanced breast cancer.Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancerMagnetic resonance imaging: a potential tool in assessing the addition of hyperthermia to neoadjuvant therapy in patients with locally advanced breast cancerPrediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detectionFeeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor?Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study.Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium.The utility of hyperthermia for local recurrence of breast cancer.Phase I study and biomarker analysis of lapatinib and concurrent radiation for locally advanced breast cancer.Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer.Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice.Ultrasound-mediated micellar drug delivery.Hyperthermia-induced drug targeting.Realistic biological approaches for improving thermoradiotherapy.Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.Hyperthermia-driven aberrations of secreted microRNAs in breast cancer in vitro.HSPB1 deficiency sensitizes melanoma cells to hyperthermia induced cell death.RADIOLABELED LIPOSOMES AS DRUG DELIVERY NANOTHERANOSTICS
P2860
Q27300805-75C3E4A3-A59A-4458-B619-FBF1A9A8528BQ27333679-977AD411-07EF-479A-A028-36E4478E1CFFQ28291499-0414ECDB-AA9E-4AED-901C-B9BB2013B750Q28468623-26F06149-2E02-444A-84A4-F78591A4D90FQ30374959-C49B4A5A-F964-4F18-8718-B401C709FF2DQ30417816-4143203F-EA0B-49C5-91CC-C8105AD60E62Q30450131-410746E9-21FD-4478-A287-F177A1BF6670Q33694703-A5EF8013-EF7E-4F59-9BE9-98831C2630D7Q34171535-A62292BA-A25D-4E70-BC5C-F5206CAE13C1Q34172879-4D9E6B82-EE97-49B7-8EF1-46C57A5ED94FQ34390068-06300B18-AA58-4EA3-91B8-886F1CCC2EDCQ34392087-E7E61C11-B203-49E3-A130-0C5241165AAEQ34449535-8CACFD9A-B461-4FFB-BB1D-09B00F322FD1Q34667806-4DA3C268-8A96-448A-A6EA-7B56017EAB51Q35667692-DB4C1D6E-0AEA-42D8-92C7-F4B5DD7EE64FQ36406854-A666A9C4-6016-4ACC-AEC6-113C223A08C9Q36483151-89432588-B556-4E34-98D4-EB6AE5C73104Q36953404-365B8E90-AD19-4FEA-9CAA-D4858702FD3DQ37114252-12C1C8CA-811B-467A-92DB-4D6D86517205Q37602839-A1C5E547-8300-42E2-B631-21648D0B2A93Q38012539-9F8140C9-6B14-4AF4-99ED-0D9CA06782EDQ38071664-1B401560-C8DB-4265-8352-1FF1295ABECCQ38648236-4C697D95-9D34-4BF7-8A23-D6257E750E16Q38656720-A21220B3-7D55-464E-AB96-027A66F9E42FQ38825691-939399C6-E659-40C3-8E69-C76061293FD3Q39630301-AB03340C-AEB5-465A-8830-5BF521A7AC8FQ41989169-947A3806-4F52-4A2A-9705-A4889F4DCE25Q57832750-A40B3ABF-EB3B-4782-917E-1B7663ED9C09
P2860
A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A phase I/II study of neoadjuv ...... ocally advanced breast cancer.
@ast
A phase I/II study of neoadjuv ...... ocally advanced breast cancer.
@en
A phase I/II study of neoadjuv ...... ocally advanced breast cancer.
@nl
type
label
A phase I/II study of neoadjuv ...... ocally advanced breast cancer.
@ast
A phase I/II study of neoadjuv ...... ocally advanced breast cancer.
@en
A phase I/II study of neoadjuv ...... ocally advanced breast cancer.
@nl
prefLabel
A phase I/II study of neoadjuv ...... ocally advanced breast cancer.
@ast
A phase I/II study of neoadjuv ...... ocally advanced breast cancer.
@en
A phase I/II study of neoadjuv ...... ocally advanced breast cancer.
@nl
P2093
P2860
P1476
A phase I/II study of neoadjuv ...... locally advanced breast cancer
@en
P2093
Dong W Kim
Ellen Jones
Kimberly Blackwell
Linda McCall
Mark W Dewhirst
Oana Craciunescu
Vlayka Liotcheva
Zeljko Vujaskovic
P2860
P304
P356
10.3109/02656731003639364
P577
2010-01-01T00:00:00Z